Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Prometheus Biosciences

Explore full profile

Committed to the discovery, development, and commercialization of novel precision therapeutics and companion diagnostics for patients living with unmet needs in gastroenterology and autoimmune disease

San Diego, United StatesFounded 1995Biotech & Life Sciences
Valuation $8.87B Market cap · 2026
Revenue $6.8M Latest reported FY

At a glance

Status
Listed
Founded
1995
Headquarters
San Diego, United States
Listing
IPO 2021
Sector
Biotech & Life Sciences
Power Law
Unicorn$1–10B valuation tier

Knowledge graph

News, research, reports and resources connected to this company by Dealroom

Investors

10 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series B and later10 investors entered at this stage

  • Ascend Global Investments
  • Nestlé
  • Cowen Group
  • RTW Investments
  • Eventide Asset Management
  • Perceptive Advisors
  • Cormorant Capital
  • Cedars-Sinai
  • Irving Investors
  • Point72

Talent

Book a demo to see the people
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia 4 alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Alumni founders

4 startups

Former Prometheus Biosciences employees who went on to found companies, sorted by Dealroom signal score.

Mirador TherapeuticsEst. 2024
MMMark McKennaUnited States
Signal score92
Phathom PharmaceuticalsEst. 2018
David SocksUnited States
Signal score75
SantarusEst. 1996
Scott GlennUnited States
Signal score70
Shoreline BiosciencesEst. 2020
William SandbornUnited States
Signal score61
Explore the full alumni networkBook a demo

Global footprint

Workforce and web traffic by country
Workforce by country
🇺🇸 United States · San Diego HQ
Book a demo for the full country breakdown

Patents

Estimated portfolio value
$52M

57 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Prometheus Biosciences on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Prometheus Biosciences on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles